Skip to main navigation Skip to search Skip to main content

Should SGLT2 inhibitors be part of standard of care for patients with insufficiently controlled type 2 diabetes? (90 minutes Webinar)

  • Peter Zeh (Chair)

    Activity: Participating in or organising an event › Participation in workshop, seminar, course

    Period17 Nov 2020
    Event typeSeminar
    LocationBirmingham, United KingdomShow on map
    Degree of RecognitionLocal